Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 01 entities : Eli lilly and company save search
Avidity Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Highlights
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
RNA | News M | $25.105 -0.14% -0.14% 560K
|
Health Technology
|
| O: 0.0%
H: 1.42%
C: -3.6%
financial results report bioscience results
Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
jardiance heart trial
AnHeart Therapeutics and Innovent Biologics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1 Fusion-Positive Non-Small Cell Lung Cancer
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.44%
H: 2.1%
C: 0.88%
heart therapeutics cel lung cancer positive cancer designation
Pulmatrix Announces Expansion of Executive Leadership Team to Progress Clinical Pipeline
Published: 2022-03-01 (Crawled : 14:30) - ir.pulmatrix.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
PULM | $2.0201 2.0% 4.1K
|
Health Technology
|
| O: 1843.63%
H: 2.17%
C: -4.67%
matrix expansion
Veru to Present at the Oppenheimer 32nd Annual Healthcare Conference on March 15-17, 2022
Published: 2022-03-01 (Crawled : 13:30) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
VERU | $1.325 3.92% 3.77% 1.5M
|
Health Technology
|
| O: -2.78%
H: 1.25%
C: -0.54%
health thc conference
Quanterix Announces New Agreements with Lilly to Advance Alzheimer’s Disease Diagnosis and Treatment
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
QTRX | $16.06 -0.25% -0.25% 350K
|
Health Technology
|
| O: 3.95%
H: 6.39%
C: -6.56%
alzheimer treatment new agreements disease alzheimer’s alzheimer's disease alzheimer's diagnostic
Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
QTRX | $16.06 -0.25% -0.25% 350K
|
Health Technology
|
| O: 3.95%
H: 6.39%
C: -6.56%
corporation results
Innovent Biologics and AnHeart Therapeutics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer
Published: 2022-03-01 (Crawled : 02:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.44%
H: 2.1%
C: 0.88%
heart therapeutics cel lung cancer positive cancer designation
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.